Literature DB >> 29782581

Correction to: CBFA2T2 is associated with a cancer stem cell state in renal cell carcinoma.

Du-Chu Chen1,2, You-De Liang3, Liang Peng2, Yi-Ze Wang4, Chun-Zhi Ai4, Xin-Xing Zhu4, Ya-Wei Yan4, Yasmeen Saeed4, Bin Yu1, Jingying Huang1, Yuxin Gao1, Jiaqi Liu1, Yi-Zhou Jiang4, Min Liu1, Demeng Chen5.   

Abstract

[This corrects the article DOI: 10.1186/s12935-017-0473-z.].

Entities:  

Year:  2018        PMID: 29782581      PMCID: PMC5948904          DOI: 10.1186/s12935-018-0564-5

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


Correction to: Cancer Cell Int (2017) 17:103 10.1186/s12935-017-0473-z

Upon publication of the original article [1] it was highlighted by the authors that a grant awarded to support the research work of the study was missed in the Funding Acknowledgements of their manuscript. It should also be acknowledged that the grant titled “Shenzhen healthcare research project” (201505025 to Youde Liang) also contributed to the resources for this research. This has since been formally noted in this correction article.
  1 in total

1.  CBFA2T2 is associated with a cancer stem cell state in renal cell carcinoma.

Authors:  Du-Chu Chen; You-De Liang; Liang Peng; Yi-Ze Wang; Chun-Zhi Ai; Xin-Xing Zhu; Ya-Wei Yan; Yasmeen Saeed; Bin Yu; Jingying Huang; Yuxin Gao; Jiaqi Liu; Yi-Zhou Jiang; Min Liu; Demeng Chen
Journal:  Cancer Cell Int       Date:  2017-11-14       Impact factor: 5.722

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.